Medical News

RSS

Six universities aim to expand drug access in developing countries

Six universities have agreed to an effort to "encourage companies to give poor countries better access to drugs and medical products stemming from discoveries made on their campuses," Bloomberg reports (Lauerman, 11/9).

10 Nov 2009

African leaders meet to discuss ways to increase access to water in Africa

In tandem with Africa Water Week, the African Minister's Council on Water (AMCOW) Summit kicked off in Johannesburg, South Africa, Monday, where discussions will center on ways to increase the water supply in Africa, BuaNews/allAfrica.com reports (11/9).

10 Nov 2009

Aduro BioTech raises funds through its Series A-1 financing

Aduro BioTech, a privately held biotechnology company focused on the development of therapeutic and prophylactic vaccines based on proprietary recombinant strains of the bacterium Listeria monocytogenes, today announced completion of its Series A-1 financing.

10 Nov 2009

NIH $1 million Challenge Grant to refine cell-tracking nanotube technology

The National Institutes of Health (NIH) has awarded researchers at Rice University and the Texas Heart® Institute (THI) a $1 million Challenge Grant to refine cell-tracking nanotube technology that could make magnetic resonance imaging (MRI) up to 40 times more sensitive than existing MRIs and help guide adult stem cells within the human body to repair damaged hearts.

10 Nov 2009

White House firm on health reform timeline, sends mixed abortion messages

Roll Call: "Even as Senate Democrats continue to grope for a way forward on health care, the White House asserted Monday that its Dec. 31 deadline for final passage of the legislation is solid. 'When we say the end of the year, we've got a pretty firm end-of-the-year deadline,' White House Press Secretary Robert Gibbs said."

10 Nov 2009

AMA sticks with House bill endorsement

The American Medical Association, the official physician lobby, reiterated its endorsement of the House bill Monday. The Associated Press/The Washington Post reports that the AMA "on Monday rebuffed dissident members and voted to stick with support for ongoing health reform efforts, while reiterating wariness over proposals that threaten doctors' pocketbooks and independence.

10 Nov 2009

Sportline introduces the META MP3 player that delivers real-time heart rate feedback

Sportline, the brand leader in fitness monitoring, has developed a new tool to help consumers integrate personal exercise data into their everyday training – the Music Enhanced Training Assistant or META.

10 Nov 2009

Bristol-Myers Squibb and Alder Biopharmaceuticals collaborate in development of novel biologic for rheumatoid arthritis

Bristol-Myers Squibb Company and Alder Biopharmaceuticals, Inc., today announced a global agreement for the development and commercialization of ALD518, a novel biologic that has completed Phase IIa development for the treatment of rheumatoid arthritis.

10 Nov 2009

BioVex completes $70M financing to complete OncoVEX Phase III study

BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March. The proceeds of the financing will primarily be used to complete the ongoing Phase III pivotal study of OncoVEX (GM-CSF) for the treatment of recurrent and metastatic melanoma and to fund pre-commercialization activities.

10 Nov 2009

Third-quarter 2009 results announced by Response Biomedical

Response Biomedical Corporation today announced financial results for the third quarter and nine months ended September 30, 2009.

10 Nov 2009

Tokai Pharmaceuticals commences TOK-001 Phase 1/2 clinical trial for treatment of castration resistant prostate cancer

Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced the initiation of a Phase 1/2 clinical trial of its lead candidate TOK-001 for the treatment of patients with castration resistant prostate cancer (CRPC). TOK-001 is the only compound in development that combines three distinct mechanisms of action for the treatment of CRPC.

10 Nov 2009

First Edition: November 10, 2009

As the focus of health overhaul efforts move to the Senate, abortion issues have become hot topics.

10 Nov 2009

Javelin Pharmaceuticals announces financial results for the third quarter of 2009

Javelin Pharmaceuticals, Inc., a leading developer of novel acute care pain products, today reported its unaudited financial results for the third quarter ended September 30, 2009.

10 Nov 2009

ImmunoGen to present IMGN901 clinical data at AACR-NCI-EORTC International Conference

ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that several ImmunoGen poster presentations will be made at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics to be held in Boston, MA, on November 15-19, 2009.

10 Nov 2009

Levulan PDT may reduce the rate of recurrence of SCCs in solid organ transplant recipients: Study

The results of an independent investigator study just published in the online version of Dermatologic Surgery demonstrate that Levulan(®) Photodynamic Therapy (PDT) may reduce the rate of recurrence of squamous cell carcinomas (SCCs) in solid organ transplant recipients (SOTRs), a population with a high incidence of nonmelanoma skin cancer.

10 Nov 2009

Scarab Genomics reduces the E. coli K-12 genome, optimizing it for recombinant DNA and protein production

Scarab Genomics has made a series of planned, precise deletions to the E. coli K-12 genome, reducing the genome by more than 15%. The multiple-deletion series (MDS™) strains eliminate non-essential genes, cryptic virulence genes, and sequences of recombinogenic and mobile insertion sequence (IS) DNA, while preserving robust growth in rich and minimal media.

10 Nov 2009

Premier Power Renewable Energy to install 300kW solar photovoltaic system at the CHE Medical Building

Premier Power Renewable Energy, a global leader in the development, design, engineering and construction of solar power systems for commercial, government and utility markets in the U.S. and Europe, today announced that it has contracted with Soar Energy Partners, LLC to install a 300kW solar photovoltaic system at the CHE Medical Building in Lakewood, NJ.

10 Nov 2009

HHS Secretary to visit Bradenton Healthcare Center to discuss the importance of H1N1 vaccinations

Health and Human Services Secretary Kathleen Sebelius will visit the East Manatee Family Healthcare Center in Bradenton, Fla. on Tuesday, November 10.

10 Nov 2009

New organic herbal products to help support body's immune system

Gaia Herbs, a leading grower and manufacturer of natural and organic herbal products, announces Quick Defense Liquid Phyto-Caps, a combination of high potency organic Echinacea, organic Elderberry, organic Ginger and Andrographis that helps support the body's immune system at onset.

10 Nov 2009

Hyperbaric oxygen therapy treatment ineffective for children with autism

Research conducted by the Center for Autism and Related Disorders, Inc. (CARD), shines new light on the effects of a popular form of hyperbaric oxygen therapy (HBOT) treatment for children with autism and related disorders. The "Randomized Trial of Hyperbaric Oxygen Therapy for Children with Autism" study reveals that HBOT, consisting of 24% oxygen delivered at 1.3 atmospheres of pressure, does not have a significant effect on symptoms of autism.

10 Nov 2009

Medical News

Six universities aim to expand drug access in developing countries

African leaders meet to discuss ways to increase access to water in Africa

Aduro BioTech raises funds through its Series A-1 financing

NIH $1 million Challenge Grant to refine cell-tracking nanotube technology

White House firm on health reform timeline, sends mixed abortion messages

AMA sticks with House bill endorsement

Sportline introduces the META MP3 player that delivers real-time heart rate feedback

Bristol-Myers Squibb and Alder Biopharmaceuticals collaborate in development of novel biologic for rheumatoid arthritis

BioVex completes $70M financing to complete OncoVEX Phase III study

Third-quarter 2009 results announced by Response Biomedical

Tokai Pharmaceuticals commences TOK-001 Phase 1/2 clinical trial for treatment of castration resistant prostate cancer

First Edition: November 10, 2009

Javelin Pharmaceuticals announces financial results for the third quarter of 2009

ImmunoGen to present IMGN901 clinical data at AACR-NCI-EORTC International Conference

Levulan PDT may reduce the rate of recurrence of SCCs in solid organ transplant recipients: Study

Scarab Genomics reduces the E. coli K-12 genome, optimizing it for recombinant DNA and protein production

Premier Power Renewable Energy to install 300kW solar photovoltaic system at the CHE Medical Building

HHS Secretary to visit Bradenton Healthcare Center to discuss the importance of H1N1 vaccinations

New organic herbal products to help support body's immune system

Hyperbaric oxygen therapy treatment ineffective for children with autism

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Modular cleanrooms: Enhancing flexibility and compliance

Latest News